Celgene Considers Sutro Bio Acquisition in $1Billion Immuno-Oncology Deal
News
Celgene is considering purchasing Sutro Biopharma, a company that they have collaborated with on development deals over the last two years. The potential deal may exceed more than $1 billion in total for the South San Francisco-based ... Read more